• search hit 16 of 36
Back to Result List

532P Phase Ib study evaluating BI 836880 (VEGF/Ang2 nanobody) in combination with ezabenlimab (BI 754091; anti-PD-1 antibody) in patients with solid tumours [Abstract]

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:N. Girard, M. Wermke, E. Ledin, D.-W. Kim, F. Ghiringhelli, J. Bennouna, T. Lesimple, E. Felip, D. Berz, J.-S. Lee, A. Jeanson, C. Mascaux, M. Voskoboynik, P. Serwatowski, M. C. Burger, H. T. Landsteiner, V. Chen, G. Jayadeva, J. Alt, Björn Hackanson
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/123132
ISSN:0923-7534OPAC
Parent Title (English):Annals of Oncology
Publisher:Elsevier BV
Place of publication:Amsterdam
Type:Article
Language:English
Year of first Publication:2021
Release Date:2025/07/17
Volume:32
Issue:Supplement 5
First Page:S597
DOI:https://doi.org/10.1016/j.annonc.2021.08.1054
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Innere Medizin mit Schwerpunkt Hämatologie und Onkologie